Ondine Biomedical (OBI) Competitors GBX 8.21 -0.29 (-3.41%) (As of 12/20/2024 10:19 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines OBI vs. ORPH, REDX, ETX, SBTX, TRX, POLB, COS, C4XD, DDDD, and SARShould you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include Open Orphan (ORPH), Redx Pharma (REDX), e-therapeutics (ETX), SkinBioTherapeutics (SBTX), Tissue Regenix Group (TRX), Poolbeg Pharma (POLB), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), and Sareum (SAR). These companies are all part of the "biotechnology" industry. Ondine Biomedical vs. Open Orphan Redx Pharma e-therapeutics SkinBioTherapeutics Tissue Regenix Group Poolbeg Pharma Collagen Solutions plc (COS.L) C4X Discovery 4D pharma Sareum Ondine Biomedical (LON:OBI) and Open Orphan (LON:ORPH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk, institutional ownership and community ranking. Does the media favor OBI or ORPH? In the previous week, Ondine Biomedical had 3 more articles in the media than Open Orphan. MarketBeat recorded 3 mentions for Ondine Biomedical and 0 mentions for Open Orphan. Ondine Biomedical's average media sentiment score of 0.29 beat Open Orphan's score of 0.00 indicating that Ondine Biomedical is being referred to more favorably in the media. Company Overall Sentiment Ondine Biomedical Neutral Open Orphan Neutral Do insiders & institutionals hold more shares of OBI or ORPH? 20.6% of Ondine Biomedical shares are held by institutional investors. 36.7% of Ondine Biomedical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is OBI or ORPH more profitable? Open Orphan's return on equity of 0.00% beat Ondine Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Ondine BiomedicalN/A -685.59% -159.71% Open Orphan N/A N/A N/A Which has higher valuation & earnings, OBI or ORPH? Open Orphan has higher revenue and earnings than Ondine Biomedical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOndine Biomedical£1.63M13.97-£14.27M-£0.03-273.67Open Orphan£34.71M0.00N/AN/AN/A Does the MarketBeat Community believe in OBI or ORPH? Ondine Biomedical received 1 more outperform votes than Open Orphan when rated by MarketBeat users. Likewise, 100.00% of users gave Ondine Biomedical an outperform vote while only 0.00% of users gave Open Orphan an outperform vote. CompanyUnderperformOutperformOndine BiomedicalOutperform Votes1100.00% Underperform VotesNo VotesOpen OrphanOutperform VotesNo VotesUnderperform Votes2100.00% SummaryOndine Biomedical beats Open Orphan on 6 of the 10 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Ondine Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBI vs. The Competition Export to ExcelMetricOndine BiomedicalBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£22.77M£165.68M£5.14B£1.90BDividend YieldN/A3.64%5.09%5.45%P/E Ratio-273.67115.5190.131,863.09Price / Sales13.9718,531.021,116.25392,686.74Price / Cash1.9912.8743.1028.61Price / BookN/A8.594.782.80Net Income-£14.27M-£20.67M£120.31M£155.77M7 Day Performance8.03%-1.05%-1.92%-2.02%1 Month Performance-0.48%174.77%13.65%21.64%1 Year Performance-6.17%134.18%28.34%29.70% Ondine Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBIOndine BiomedicalN/AGBX 8.21-3.4%N/A-6.2%£22.77M£1.63M-273.67N/AGap DownORPHOpen OrphanN/AGBX 10+5.3%N/A+0.0%£67.09M£34.71M-25.30179REDXRedx PharmaN/AGBX 15+31.6%N/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeETXe-therapeuticsN/AGBX 9-6.7%N/AN/A£52.59M£295,000.00-450.0035Negative NewsHigh Trading VolumeSBTXSkinBioTherapeuticsN/AGBX 18.99+0.5%N/A+6.5%£42.93M£21,949.00-949.5011TRXTissue Regenix GroupN/AGBX 58.03+0.1%N/A+6.8%£41.34M£31.80M-5,800.00120News CoveragePOLBPoolbeg PharmaN/AGBX 7.37+2.4%N/A-23.2%£36.85MN/A-720.0012Gap UpCOSCollagen Solutions plc (COS.L)N/AGBX 6.63flatN/A+0.0%£30.99M£4.01M-8.283,350C4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AGBX 16.66flatN/AN/A£30.05M£718,000.00-1.08106News CoverageSARSareumN/AGBX 260.0%N/A-51.7%£28.07M£47,204.00-441.673,211 Related Companies and Tools Related Companies Open Orphan Competitors Redx Pharma Competitors e-therapeutics Competitors SkinBioTherapeutics Competitors Tissue Regenix Group Competitors Poolbeg Pharma Competitors Collagen Solutions plc (COS.L) Competitors C4X Discovery Competitors 4D pharma Competitors Sareum Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:OBI) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBI Stock Alerts